Top compounds associated with response to CCDC170


Feature Type Standardized
Nominal ANOVA
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.21 5e-06
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.17 0.0005
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA paclitaxel gCSI pan-cancer AAC -0.18 0.001
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.12 0.001
mRNA Rapamycin gCSI pan-cancer AAC -0.18 0.001
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.18 0.002
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV